N-(6-aminohexyl)-5-chloro-naphthalene-1-sulfomide (W-7) and trifluoperazine (TFP) inhibit ACTH release. These drugs impact corticotropin-releasing factor (CRF) and arginine vasopressin (AVP) pathways differently, suggesting distinct mechanisms for ACTH stimulation.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: